Literature DB >> 29700791

Patients' Perception of Newly Initiated Oral Anticoagulant Treatment for Atrial Fibrillation: an Observational Study.

Josiane Larochelle1, Caroline Brais2, Lucie Blais3,4, Sylvie Perreault3, Paul Farand5,6, Geneviève Letemplier5,6, Marie-France Beauchesne7,8,9,10,11.   

Abstract

Entities:  

Keywords:  apixaban; atrial fibrillation; dabigatran; oral anticoagulants; rivaroxaban; warfarin

Mesh：

Substances：

Year:  2018        PMID： 29700791      PMCID： PMC6082223          DOI： 10.1007/s11606-018-4457-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  6 in total

1.  [Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants].

Authors:  Sarah Fareau; Karine Baumstarck; Anaïs Farcet; Catherine Molines; Pascal Auquier; Frédérique Retornaz
Journal:  Geriatr Psychol Neuropsychiatr Vieil       Date:  2015-03

Review 2.  Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.

Authors:  Gemma Mas Dalmau; Elisenda Sant Arderiu; María Belén Enfedaque Montes; Ivan Solà; Sandra Pequeño Saco; Pablo Alonso Coello
Journal:  BMC Fam Pract       Date:  2017-01-13       Impact factor: 2.497

3.  Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q).

Authors:  Martin H Prins; Alexia Marrel; Paulo Carita; David Anderson; Marie-Germaine Bousser; Harry Crijns; Silla Consoli; Benoit Arnould
Journal:  Health Qual Life Outcomes       Date:  2009-02-06       Impact factor: 3.186

4.  Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).

Authors:  M H Prins; I Guillemin; H Gilet; S Gabriel; B Essers; G Raskob; S R Kahn
Journal:  Health Qual Life Outcomes       Date:  2009-04-07       Impact factor: 3.186

5.  Psychological effects of treatment with new oral anticoagulants in elderly patients with atrial fibrillation: a preliminary report.

Authors:  Stefano Fumagalli; Francesca Cardini; Anna T Roberts; Serena Boni; Debbie Gabbai; Silvia Calvani; Marta Casalone Rinaldi; Stefania Manetti; Francesca Tarantini; Niccolò Marchionni
Journal:  Aging Clin Exp Res       Date:  2014-06-01       Impact factor: 3.636

6.  Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study.

Authors:  Olivier Hanon; Edouard Chaussade; Pierre Gueranger; Elise Gruson; Sabrina Bonan; Alain Gay
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240
  6 in total
  3 in total

1.  A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants.

Authors:  Saima Kishvar Afzal; Syed Shahzad Hasan; Zaheer Ud-Din Babar
Journal:  Br J Clin Pharmacol       Date:  2019-06-26       Impact factor: 4.335

2.  Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study.

Authors:  Young-Soo Lee; Yong Seog Oh; Eue-Keun Choi; Alan Koay Choon Chern; Panyapat Jiampo; Aurauma Chutinet; Dicky Armein Hanafy; Prabhav Trivedi; Dongmei Zhai
Journal:  Open Heart       Date:  2021-12

3.  Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants.

Authors:  Hillary J Mull; Marlena H Shin; Ryann L Engle; Amy M Linsky; Emily Kalver; Rebecca Lamkin; Jennifer L Sullivan
Journal:  Patient Prefer Adherence       Date:  2020-10-13       Impact factor: 2.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.